Adage Capital Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

Adage Capital Partners’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-925,000	Closed	-$4.6M	–	1148
2021 Q1	$4.6M	Sell	925,000 -750,000	-45%	-$3.62M	0.01%	808
2020 Q4	$7.22M	Hold	1,675,000	–	–	0.02%	647
2020 Q3	$7.19M	Hold	1,675,000	–	–	0.02%	576
2020 Q2	$7.52M	Sell	1,675,000 -25,000	-1%	-$112K	0.02%	562
2020 Q1	$6.8M	Buy	1,700,000 +50,000	+3%	+$425K	0.02%	533
2019 Q4	$14M	Hold	1,650,000	–	–	0.03%	475
2019 Q3	$11.3M	Hold	1,650,000	–	–	0.03%	498
2019 Q2	$13.7M	Hold	1,650,000	–	–	0.03%	448
2019 Q1	$15.1M	Buy	1,650,000 +615,000	+59%	+$6.25M	0.04%	449
2018 Q4	$11.3M	Buy	1,035,000 +85,000	+9%	+$1.07M	0.03%	484
2018 Q3	$13.3M	Sell	950,000 -25,000	-3%	-$338K	0.03%	506
2018 Q2	$10.4M	Buy	+975,000	New	+$9.51M	0.02%	556
2014 Q3	–	Sell	-1,075,825	Closed	-$20.1M	–	763
2014 Q2	$20.1M	Buy	1,075,825 +29,453	+3%	+$500K	0.05%	396
2014 Q1	$19.4M	Sell	1,046,372 -275,000	-21%	-$5.24M	0.05%	389
2013 Q4	$14.8M	Buy	+1,321,372	New	+$15.7M	0.04%	454

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Adage Capital Partners's KIN Position: Q2 2021 in Review

Adage Capital Partners sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 925,000 shares — an estimated $4.6M sold.

Adage Capital Partners first reported a position in KIN in Q4 2013 and held it in 15 quarters. The position peaked at $20.1M in Q2 2014. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

Adage Capital Partners reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
Adage Capital Partners sold 925,000 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $4.6M.
Adage Capital Partners first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 15 quarters.
Adage Capital Partners's Kindred Biosciences, Inc. position peaked at $20.1M in Q2 2014.
87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.